MGMohammad Ghaziuddin

Mohammad Ghaziuddin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mohammad Ghaziuddin has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Knowledge, Experience, and Attitudes Toward Electroconvulsive Therapy Among Psychiatrists in Uzbekistan

    by Bulat Chembaev, Neera Ghaziuddin, Zarifjon Ashurov, Mohammad Ghaziuddin

    Background: Electroconvulsive therapy (ECT) is among the most effective treatments for severe and treatment-resistant psychiatric disorders but remains underused in many low- and middle-income countries because of limited training and negative attitudes. To our knowledge, no previous study has examined psychiatrists’ knowledge of, experience with, and attitudes toward ECT in Central Asia. Methods: We conducted a cross-sectional anonymous survey of psychiatrists in Uzbekistan. A 33-item questionnaire assessed knowledge, clinical exposure, and attitudes toward ECT across age groups and psychiatric diagnoses. Group comparisons were performed using Kruskal-Wallis and χ 2 tests. Multivariable logistic and linear regression analyses identified independent predictors of favorable attitudes and ECT knowledge. Results: Of 212 respondents (response rate 37.6%), 44.3% reported no previous ECT exposure. Misconceptions were common: 19.8% believed ECT is administered without anesthesia, 39.6% believed psychiatric medications should be discontinued before treatment, and 65.1% considered pregnancy a contraindication. Restrictive attitudes toward ECT in children and older adults were also common. Direct clinical and indirect ECT exposure were independently associated with greater knowledge and more favorable attitudes. Rural practice location and exclusive child and adolescent practice independently predicted lower knowledge, whereas female psychiatrists were less likely to recommend ECT as a treatment option for a friend or relative. Conclusions: Psychiatrists in Uzbekistan reported limited ECT training and experience, substantial knowledge gaps, and restrictive attitudes toward ECT. Clinical exposure was the strongest independent predictor of greater knowledge and more favorable attitudes, supporting the importance of expanding supervised ECT training and educational opportunities.

  • Open Access

    Catatonia and diagnostic challenges in transition-age youth: lessons from Central Asia for LMIC psychiatry

    by Mohammad Ghaziuddin

    Catatonia remains under-recognised in many low- and middle-income countries, particularly in transition-age youth (15–25 years). This is especially relevant in parts of Central Asia, where diagnostic traditions have historically emphasised schizophrenia. Drawing on clinical observations and existing literature, this paper highlights how limited recognition of adult autism and catatonia may contribute to diagnostic uncertainty and missed treatment opportunities. Catatonia is frequently treatable yet insufficiently incorporated into psychiatric training and service development in resource-limited settings. Strengthening of diagnostic precision, training in catatonia assessment and research in transition-age populations would represent achievable steps towards improving mental health in low- and middle-income country settings.

  • Open Access

    Co-occurrence of Autism, Psychosis and Catatonia: A Scoping Review

    by Johan Nyrenius, Eric Zander, Mohammad Ghaziuddin, Neera Ghaziuddin

    Purpose: Autism, psychosis and catatonia were once considered part of schizophrenia. While both autism and catatonia have been “detached” from schizophrenia, co-occurrence of the three conditions may be suspected in some cases, because of overlapping features, leading to challenges in diagnosis and treatment. This review provides an overview of the literature regarding the co-occurrence of autism, psychosis and catatonia. Methods: A scoping review of peer-reviewed original research articles that simultaneously described all the three diagnostic constructs (autism, psychosis and catatonia) was performed. Using PRISMA-ScR guidelines, the review was based on MedLine, Scopus, PsycInfo and Cinahl databases. Studies included patients of all ages, races and both genders. A Qualitative Content Analysis (QCA) of the contents of the articles was also performed. Results: Seventeen articles ( n = 17) out of a total of 752 (after removing duplicates) met inclusion criteria, most of which (65%) were case reports/case series. Overall, majority of the studies lacked description of diagnostic procedures regarding psychosis - especially while describing co-occurrence of psychosis and catatonia in patients with autism. Reports of treatment outcomes showed considerable variations. Major themes identified in the QCA involved uncertainty, particularly in the differential diagnostic and treatment considerations. Conclusion: The results of this scoping review underscore a need for undertaking larger studies using structured diagnostic approaches for developing better methods to differentiate between autism, psychosis and catatonia. Our findings also point to a need for conducting treatment trials and developing treatment algorithms for mixed presentations when there is co-occurrence of autism, psychosis and catatonia.

  • Open Access

    A Cross-National Reliability Study of Catatonia in Individuals with Neurodevelopmental Disorders

    by Mohammad Ghaziuddin, Neera Ghaziuddin, Carina Gillberg, Elisabeth Fernell, Valdemar Landgren, Christopher Gillberg

    Catatonia is a neuropsychiatric disorder characterized by abnormalities of movement, communication, and behavior, often accompanied by a disturbance of mood, thought and perception. If untreated, it may lead to serious complications, including death. Although often described in adults with schizophrenia and severe mood disorders, it can also occur in persons with neurodevelopmental disorders (NDD), particularly autism spectrum disorder (ASD). Since its diagnosis is more likely to be missed by clinicians with limited experience, we attempted to determine if experienced psychiatrists can make a reliable diagnosis of catatonia in a group of patients with NDD. Twenty patients with catatonia with ASD/NDD (12 males 8 females; age range 13–34 years; mean 17.5; SD 4.8), diagnosed by two American psychiatrists, were re-evaluated by a group of Swedish psychiatrists. In the initial round, agreement was reached in 15 (75%) cases. However, a careful review of additional material and several virtual discussions were required to reach agreement in the remaining 5 (25%) of cases. The diagnosis of catatonia in individuals with NDD is challenging, even for experienced clinicians. Reasons for the lack of diagnostic agreement in the five patients are discussed to highlight the barriers for accurately diagnosing catatonia in patients with NDD.


  • The Sensory Profiles, Eating Behaviors, and Quality of Life of Children with Autism Spectrum Disorder and Avoidant/Restrictive Food Intake Disorder

    by Reyhan Calisan Kinter, Burcu Ozbaran, Ipek Inal Kaleli, Sezen Kose, Tezan Bildik, Mohammad Ghaziuddin

    Eating disorders frequently accompany autism spectrum disorder (ASD). One such novel eating disorder is avoidant/restrictive food intake disorder (ARFID). This study compares the eating attitudes, quality of life, and sensory processing of typically developing children (TDC), autistic children, and autistic children with ARFID. A total of 111 children aged 4–10 with a diagnosis of ASD and ARFID (n = 37), ASD without ARFID (n = 37), and typical development (n = 37) were recruited. After an interview in which Childhood Autism Rating Scale (CARS) was administered, Child Eating Behavior Questionnaire (CEBQ), Pediatric Quality of Life Inventory (PedsQL), Social Responsiveness Scale (SRS) and Sensory Profile (SP) were completed by caregivers. Autistic children with ARFID had higher scores in CEBQ subscales relating to low appetite and lower scores on the subscales associated with weight gain. Both groups of autistic children scored lower than TDC on all PedsQL subscales and autistic children with ARFID had lower social QL scores than both groups. SRS scores were highest in autistic children with ARFID, followed by autistic and typically developing children. CARS scores were similar in both groups of autistic children, but higher than TDC. Auditory, vision, touch, multi-sensory, oral processing scores; as well as all quadrant scores, were significantly lower in autistic children with ARFID. Oral sensory processing scores were found to be the most significant predictor of ARFID comorbidity in ASD and reliably predicted ARFID in autistic children in the clinical setting. Autistic children with ARFID demonstrate differences in social functioning, sensory processing, eating attitudes, and quality of life compared to autistic and TD children.


  • Open Access

    Autism and ADHD in the Era of Big Data; An Overview of Digital Resources for Patient, Genetic and Clinical Trials Information

    by Faris M. Abomelha, Hesham AlDhalaan, Mohammad Ghaziuddin, Nada A. Al-Tassan, Bashayer R. Al-Mubarak

    Even in the era of information “prosperity” in the form of databases and registries that compile a wealth of data, information about ASD and ADHD remains scattered and disconnected. These data systems are powerful tools that can inform decision-making and policy creation, as well as advancing and disseminating knowledge. Here, we review three types of data systems (patient registries, clinical trial registries and genetic databases) that are concerned with ASD or ADHD and discuss their features, advantages and limitations. We noticed the lack of ethnic diversity in the data, as the majority of their content is curated from European and (to a lesser extent) Asian populations. Acutely aware of this knowledge gap, we introduce here the framework of the Neurodevelopmental Disorders Database (NDDB). This registry was designed to serve as a model for the national repository for collecting data from Saudi Arabia on neurodevelopmental disorders, particularly ASD and ADHD, across diverse domains.


  • Open Access

    Catatonia: A Common Cause of Late Regression in Autism

    by Mohammad Ghaziuddin

    Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by social communication deficits and restricted interests and behaviors which begin very early in life. In about a quarter of cases, the symptoms emerge about 18–24 months after a period of normal development, a phenomenon commonly described as early regression. However, marked functional decline can also occur in persons with autism after a relatively stable childhood. As opposed to early regression, which occurs in normally developing children, late regression occurs typically in adolescents with an established diagnosis of autism. Apart from their occasional mention in the literature, these individuals have not been examined systematically. This Brief Report describes the presentation, comorbidity and short-term outcome of 20 persons with ASD who developed late regression. The mean age of onset of regression was 13 years. One of the earliest symptoms was an increase in obsessive slowing and compulsive rituals. Other symptoms included motor abnormalities, aggression and mood disturbance. The most common comorbid disorder was catatonia occurring in 17 patients. Despite treatment with several modalities, the outcome was often suboptimal. These findings suggest that catatonia is a common cause of late regression in persons with autism. Clinical and research implications are discussed.


  • Bipolar Disorder and Psychosis in Autism

    by Mohammad Ghaziuddin, Neera Ghaziuddin


  • Open Access

    Adapting evidence-based clinical practice guidelines for people with attention deficit hyperactivity disorder in Saudi Arabia: process and outputs of a national initiative

    by Fahad A. Bashiri, Turki H. Albatti, Muddathir H. Hamad, Haya F. Al-Joudi, Hadeel F. Daghash, Saleh M. Al-Salehi, Jeremy L. Varnham, Fatimah Alhaidar, Omar Almodayfer, Abdulkarim Alhossein, et al.

    Background: We recently adapted the published National Institute for Health and Care Excellence (NICE) Attention deficit hyperactivity disorder (ADHD) diagnosis and management guideline to the Saudi Arabian context. It has been postulated that adaptation of evidence-based clinical practice guidelines to the local healthcare context rather than de-novo development will improve their adoption and implementation without imposing a significant burden on resources. The objective of this paper is to describe the adaptation process methodology utilized for the generation of the first national guideline for management of people with ADHD in Saudi Arabia.Methods: We used the KSU-Modified-ADAPTE methodology for the guideline adaptation process. We describe the full process in detail including the three phases of set-up, adaptation, and finalization. The process was conducted by a multidisciplinary guideline adaptation group in addition to an external review for the clinical content and methodology.Results: The group adapted ten main categories of recommendations from one source CPG (NICE). The recommendations include: (i) service organisation and training, (ii) recognition, identification and referral, (iii) diagnosis, (iv) support, (v) managing ADHD, (vi) dietary advice, (vii) medication, (viii) maintenance and monitoring, (ix) adherence to treatment, and (x) review of medication and discontinuation. Several implementation tools were compiled and developed to enhance implementability including a clinical algorithm, quality measures, coding system, medication tables, translations, patient information, and online resources.Conclusions: The finalized clinical practice guideline provides healthcare providers with applicable evidence-based guidance for the management of people with ADHD in Saudi Arabia. The project also demonstrated the effectiveness of KSU-Modified-ADAPTE, and emphasized the value of a collaborative clinical and methodological expert group for adaptation of national guidelines.